Cost effectiveness and projected national impact of colorectal cancer screening in France

Cesare Hassan; R. Benamouzig; Cristiano Spada; T. Ponchon; A. Zullo; J. C. Saurin; Guido Costamagna

doi:10.1055/s-0030-1256409

Cost effectiveness and projected national impact of colorectal cancer screening in France

Cesare Hassan, R. Benamouzig, Cristiano Spada, T. Ponchon, A. Zullo, J. C. Saurin, Guido Costamagna

Risultato della ricerca: Contributo in rivista › Articolo in rivista

46 Citazioni (Scopus)

Abstract

Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.

Lingua originale	English
pagine (da-a)	780-793
Numero di pagine	14
Rivista	Endoscopy
Volume	43
DOI	https://doi.org/10.1055/s-0030-1256409
Stato di pubblicazione	Pubblicato - 2011

Keywords

Capsule Endoscopy
Colonoscopy
Colorectal Neoplasms
Computer Simulation
Cost-Benefit Analysis
France
Humans
Markov Chains
Mass Screening
Occult Blood
Sigmoidoscopy

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1055/s-0030-1256409

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{e9fc992f54b54c1192bf47b3ee2ae893,

title = "Cost effectiveness and projected national impact of colorectal cancer screening in France",

abstract = "Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.",

keywords = "Capsule Endoscopy, Colonoscopy, Colorectal Neoplasms, Computer Simulation, Cost-Benefit Analysis, France, Humans, Markov Chains, Mass Screening, Occult Blood, Sigmoidoscopy, Capsule Endoscopy, Colonoscopy, Colorectal Neoplasms, Computer Simulation, Cost-Benefit Analysis, France, Humans, Markov Chains, Mass Screening, Occult Blood, Sigmoidoscopy",

author = "Cesare Hassan and R. Benamouzig and Cristiano Spada and T. Ponchon and A. Zullo and Saurin, {J. C.} and Guido Costamagna",

year = "2011",

doi = "10.1055/s-0030-1256409",

language = "English",

volume = "43",

pages = "780--793",

journal = "Endoscopy",

issn = "1438-8812",

publisher = "Georg Thieme Verlag Stuttgart:Postfach 301120, D-70451 Stuttgart Germany:011 49 711 8931321, EMAIL: [email protected], INTERNET: http://www.thieme.de, Fax: 011 49 711 8931422",

}

TY - JOUR

T1 - Cost effectiveness and projected national impact of colorectal cancer screening in France

AU - Hassan, Cesare

AU - Benamouzig, R.

AU - Spada, Cristiano

AU - Ponchon, T.

AU - Zullo, A.

AU - Saurin, J. C.

AU - Costamagna, Guido

PY - 2011

Y1 - 2011

N2 - Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.

AB - Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.

KW - Capsule Endoscopy

KW - Colonoscopy

KW - Colorectal Neoplasms

KW - Computer Simulation

KW - Cost-Benefit Analysis

KW - France

KW - Humans

KW - Markov Chains

KW - Mass Screening

KW - Occult Blood

KW - Sigmoidoscopy

KW - Capsule Endoscopy

KW - Colonoscopy

KW - Colorectal Neoplasms

KW - Computer Simulation

KW - Cost-Benefit Analysis

KW - France

KW - Humans

KW - Markov Chains

KW - Mass Screening

KW - Occult Blood

KW - Sigmoidoscopy

UR - http://hdl.handle.net/10807/5979

U2 - 10.1055/s-0030-1256409

DO - 10.1055/s-0030-1256409

M3 - Article

SN - 1438-8812

VL - 43

SP - 780

EP - 793

JO - Endoscopy

JF - Endoscopy

ER -

Cost effectiveness and projected national impact of colorectal cancer screening in France

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo